Aster Capital Management’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Aster Capital Management’s Portfolio KRSA Stock Details KRSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$137K	Buy	+4,276	New	+$119K	0.05%	406

Other funds holding KRSA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Aster Capital Management's KRSA Position: Q3 2026 in Review

Aster Capital Management opened a new position in Korsana Biosciences, Inc. Common Stock (KRSA) in Q3 2026: 4,276 shares worth $137K. The stake represents 0.05% of the portfolio and ranks #406 among its holdings.

10 funds tracked by Wall St. Rank hold KRSA as of Q3 2026.

Aster Capital Management held 4,276 shares of Korsana Biosciences, Inc. Common Stock worth $137K as of Q3 2026.
Korsana Biosciences, Inc. Common Stock was a new Aster Capital Management position in Q3 2026.
Korsana Biosciences, Inc. Common Stock made up 0.05% of Aster Capital Management's portfolio in Q3 2026, its #406 holding.
10 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.